New York, NY – The recent approval by the FDA of Opill, the first over-the-counter birth control pill, marks a significant milestone in women’s healthcare accessibility. The pill is set to become available later this month, offering a more convenient and affordable option for women seeking reliable contraceptive methods.
Opill, manufactured by Perrigo, will be sold online and in pharmacies for varying prices – $19.99 for a month’s supply, $49.99 for three months, or $89.99 for six months. This move eliminates the need for a doctor’s prescription, potentially reducing barriers for women with limited access to healthcare services or insurance coverage.
After being on the market as a prescription drug for 50 years, Opill’s transition to over-the-counter status was approved by the FDA in July. The product is expected to be stocked at major retailers like CVS and Walgreens across the country, as well as available for direct purchase through the Opill website. Preorders will soon be accepted from select retailers.
The affordability of Opill will play a crucial role in determining its accessibility to different demographics. While insurance plans typically cover prescription contraceptives under the Affordable Care Act, coverage for over-the-counter options varies among states. Those without insurance or seeking privacy may opt to pay out of pocket, ranging from $15 to $20 per month depending on the supply plan selected.
Research from a November 2022 survey conducted by KFF reveals that willingness to pay for over-the-counter birth control varies among women. Approximately 39% are willing to spend $1-10 per month, while 34% are willing to pay $11-20. However, 11% indicate an unwillingness to pay anything for OTC contraceptives.
To address affordability concerns, Opill has announced plans for a cost-assistance program to support low-income and uninsured individuals in obtaining the product at reduced or no cost. This initiative aims to make Opill more accessible to those facing financial constraints.
Overall, the availability of Opill as an over-the-counter option signifies a step towards greater contraceptive accessibility and empowerment for women. With a focus on convenience and affordability, this innovative product has the potential to reshape the landscape of birth control options for individuals across the country.